1391 Results

People

  1. Vickers
    Vickers
  2. Adusumilli
    Adusumilli
  3. Marghoob
    Marghoob
  4. Scordo
    Scordo
  5. Levine
    Levine
  6. Saltz
    Saltz
  7. Cheung
    Cheung
  8. Ladanyi
    Ladanyi
  9. Lee
    Lee
  10. Abramson
    Abramson

Groups

  1. Department of Medicine (456)
  2. Surgery (266)
  3. Survivorship Research (205)
  4. Population Sciences Research Program (201)
  5. Solid Tumor Oncology Division (179)
  6. Center for Hematologic Malignancies (171)
  7. Epidemiology and Biostatistics (171)
  8. Hematologic Malignancies, Division of (170)
  9. GSK Faculty (152)
  10. Division of Subspecialty Medicine (146)
  1. "letter"
Formats
  1. Journal Article (990)
  2. Correspondence (221)
  3. Research Letter (168)
  4. Editorial (10)
  5. Miscellaneous (1)
  6. Review (1)
Groups
  1. Department of Medicine (456)
  2. Surgery (266)
  3. Survivorship Research (205)
  4. Population Sciences Research Program (201)
  5. Solid Tumor Oncology Division (179)
  6. Center for Hematologic Malignancies (171)

More Groups

People
  1. Andrew Vickers (46)
  2. Ashfaq Marghoob (18)
  3. Michael Scordo (18)
  4. Peter Bach (18)
  5. Prasad Adusumilli (18)
  6. Leonard Saltz (17)

More People

Years
  1. 2025 (45)
  2. 2024 (105)
  3. 2023 (67)
  4. 2022 (63)
  5. 2021 (32)
  6. 2020 (69)

More Years

Publications
  1. Journal of Clinical Oncology (118)
  2. New England Journal of Medicine (92)
  3. International Journal of Radiation Oncology, Biology, Physics (50)
  4. European Urology (33)
  5. JNCI: Journal of the National Cancer Institute (32)
  6. Leukemia and Lymphoma (32)

More Publications

Publishers
  1. Elsevier Inc. (154)
  2. Elsevier Science, Inc. (130)
  3. American Society of Clinical Oncology (120)
  4. Nature Publishing Group (98)
  5. Lippincott Williams & Wilkins (95)
  6. Massachusetts Medical Society (92)

More Publishers

Results (1391)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • What really matters with thrombocytopenia: Absolute value, timing, etiology or management? Author's reply
    Correspondence

    Anthon, C. T.; Pène, F.; Chawla, S.; Puxty, K.; Russell, L.
    Intensive Care Medicine (2024)

    Fulltext@MSK | Save
  • Response letter to “Stereotactic body radiation therapy for pleural mesothelioma: Which goal, which patients”
    Correspondence

    Shin, J. Y.; Offin, M.; Simone, C. B.; Shepherd, A. F.; Wu, A. J.; Shaverdian, N.; Gelblum, D. Y.; Gomez, D. R.; Sauter, J. L.; Ginsberg, M. S.; more...
    Radiotherapy and Oncology (2024)

    Fulltext@MSK | Save
  • Brentuximab vedotin with chemotherapy in adolescents and young adults with stage III or IV classical Hodgkin lymphoma in ECHELON-1
    Research Letter

    Crosswell, H. E.; LaCasce, A. S.; Bartlett, N. L.; Straus, D. J.; Savage, K. J.; Zinzani, P. L.; Collins, G. P.; Fanale, M.; Fenton, K.; Dong, C.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • Acute myeloid leukemia stratifies as 2 clinically relevant sphingolipidomic subtypes
    Research Letter

    Paudel, B. B.; Tan, S. F.; Fox, T. E.; Ung, J.; Golla, U.; Shaw, J. J. P.; Dunton, W.; Lee, I.; Fares, W. A.; Patel, S.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Temporal trends in guideline-recommended cardiometabolic testing completeness before initiating immune checkpoint inhibitors: A cohort study
    Research Letter

    Chan, J. S. K.; Chou, O. H. I.; Lee, T. T. L.; Lee, Y. H. A.; Chan, R. N. C.; Dee, E. C.; Ng, K.; Liu, T.; Tse, G.
    Journal of Internal Medicine (2024)

    Fulltext@MSK | Save
  • Association of previously irradiated stable brain metastases with outcomes of atezolizumab-treated non-small cell lung cancer: A pooled analysis of individual patient data from three randomized trials
    Research Letter

    Guo, T.; Zhou, Y.; Liang, F.; Wang, Z.; Bourbonne, V.; Käsmann, L.; Sundahl, N.; Jing-Ching Wu, A.; Ni, J.; Zhu, Z.
    Cancer Communications (2024)

    Fulltext@MSK | Save
  • Gemcitabine plus pembrolizumab after checkpoint blockade failure as a strategy in multiply relapsed Hodgkin lymphoma
    Research Letter

    Stuver, R.; Noy, A.; Vardhana, S. A.; Zelenetz, A. D.; Moskowitz, A. J.
    British Journal of Haematology (2024)

    Fulltext@MSK | Save
  • Federal oversight of laboratory-developed tests
    Correspondence

    Sholl, L. M.; Adem, P.
    New England Journal of Medicine (2024)

    Fulltext@MSK | Save
  • In reply to Onjukka et al
    Correspondence

    Milano, M. T.; Mavroidis, P.; Yorke, E.; Ryckman, J.; Kong, F. M. S.; Grimm, J.; Marks, L. B.
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Ovarian endometrioid adenocarcinomas with infiltrative "adenofibroma-like" morphology and aberrant ß-catenin expression: Tumors that coexpress CDX2 and LEF1 with frequent neuroendocrine marker expression, diminished/lost PAX8 and possible association with endometrioid type II stem cell outgrowths in the fallopian tube
    Correspondence

    Xu, J.; McGregor, S. M.; Park, K. J.; Weisman, P. S.
    International Journal of Gynecological Pathology (2024)

    Fulltext@MSK | Save